LIVZON PHARMA - An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

does not make any representation about the accuracy or completeness of this announcement and expressly disclaims any liability arising out of or in connection with all or any part of this announcement.

We accept no liability for any loss caused by reliance on such content.

Overseas regulatory announcement

This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

This is to set forth the "Livzon Pharmaceutical Group Co., Ltd." published on the website of the Shenzhen Stock Exchange Co., Ltd.’s announcement on the estimated application for comprehensive credit and guarantee limits in 2026" is for reference only.

By order of the board of directors

Livzon Pharmaceutical Group Co., Ltd. Livzon Pharmaceutical Group Inc.* company secretary Liu Ning

China, Zhuhai March 24, 2026

As of the date of this announcement, the executive director of the company is Mr. Tang Yanggang (vice chairman); the non-executive director of the company is Mr. Zhu Baoguo. Sheng (Chairman), Mr. Lin Nanqi and Mr. Qiu Qingfeng; the company’s employee director is Ms. Ran Yongmei; and the company’s independence is not

The executive directors are Mr. Bai Hua, Mr. Luo Huiyuan, Ms. Cui Lijie and Ms. Wang Zhiyao.

*Identification only

Securities code: 000513, 01513 Securities abbreviation: Livzon Group, Livzon Pharmaceutical Announcement number: 2026-13

Livzon Pharmaceutical Group Co., Ltd.

Announcement on the estimated application for comprehensive credit and guarantee lines in 2026

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and there are no false records.

information, misleading statements or material omissions.

Special tips: ●Livzon Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") plans to apply to the bank for the highest

A comprehensive credit limit not exceeding RMB 1,280,000,000 or its equivalent in foreign currency.

●The company plans to provide financing guarantees for its subsidiaries, and the guarantee amount is expected to not exceed RMB

11,678.25 million yuan, all of which are guarantee lines for subsidiaries with asset-liability ratios below 70%. Reminder to invest

Investors pay full attention to guarantee risks.

On March 24, 2026, the company held the 33rd meeting of the 11th Board of Directors, which reviewed and approved

The "Proposal on Application for Comprehensive Credit and Guarantee Amount Estimation in 2026" has been issued. This matter still needs to be submitted to the public. The company's shareholders meeting has reviewed and the relevant information is hereby announced as follows:

1. Overview of application for comprehensive credit and estimated guarantee amount for subsidiaries

(1) Apply for comprehensive credit

According to the company's daily operations and business development needs, the company plans to apply to the bank for a maximum of no more than RMB

A comprehensive credit line of RMB 12,800,000,000 or its equivalent in foreign currency, used to handle transactions including but not limited to working capital (Loan) credit, asset pool financing, bank credit line, non-financing letter of guarantee, trade financing (letter of credit)

Medium and long-term loans and comprehensive credit financing business (specific business products) such as credit, factoring, and export financing under credit insurance

(subject to approval by relevant financial institutions), details are as follows:

Serial number Credit bank name Currency Application credit limit (yuan) Remarks 1 China Development Bank RMB 300,000,000.00 or equivalent in foreign currency

2 Export-Import Bank of China RMB 300,000,000.00 or equivalent in foreign currency 3 Bank of China Co., Ltd. RMB 1,000,000,000.00 or equivalent in foreign currency

4 Agricultural Bank of China Co., Ltd. RMB 500,000,000.00 or equivalent in foreign currency

Serial number Credit bank name Currency Application credit limit (yuan) Remarks 5 Industrial and Commercial Bank of China Co., Ltd. RMB 1,700,000,000.00 or equivalent in foreign currency

6 China Construction Bank Co., Ltd. RMB 1,300,000,000.00 or equivalent in foreign currency

7 Bank of Communications Co., Ltd. RMB 700,000,000.00 or equivalent in foreign currency 8 Postal Savings Bank of China Co., Ltd. RMB 250,000,000.00 or equivalent in foreign currency

9 China Merchants Bank Co., Ltd. RMB 1,100,000,000.00 or equivalent in foreign currency 10 China Minsheng Bank Co., Ltd. RMB 400,000,000.00 or equivalent in foreign currency

11 China Everbright Bank Co., Ltd. RMB 900,000,000.00 or equivalent in foreign currency 12 China CITIC Bank Co., Ltd. RMB 500,000,000.00 or equivalent in foreign currency

13 Industrial Bank Co., Ltd. RMB 300,000,000.00 or equivalent in foreign currency 14 Shanghai Pudong Development Bank Co., Ltd. RMB 250,000,000.00 or equivalent in foreign currency

15 Ping An Bank Co., Ltd. RMB 750,000,000.00 or equivalent in foreign currency 16 Hua Xia Bank Co., Ltd. RMB 200,000,000.00 or equivalent in foreign currency

17 Zheshang Bank Co., Ltd. RMB 300,000,000.00 or equivalent in foreign currency 18 Bohai Bank Co., Ltd. RMB 100,000,000.00 or equivalent in foreign currency

19 Zhuhai China Resources Bank Co., Ltd. RMB 200,000,000.00 or equivalent in foreign currency 20 Standard Chartered Bank (China) Co., Ltd. RMB 1,000,000,000.00 or equivalent in foreign currency

21 HSBC Bank (China) Co., Ltd. RMB 650,000,000.00 or equivalent in foreign currency 22 Morgan Stanley International Bank (China) Co., Ltd. RMB 100,000,000.00 or equivalent in foreign currency

Total RMB 12,800,000,000.00 The validity period of the above-mentioned comprehensive credit line is from the date of review and approval at the 2025 annual shareholders’ meeting to the company’s next

until the date of the first shareholders’ meeting to consider the matter. Within the credit period, the credit limit can be recycled.

Within the total credit limit, the company can transfer funds between different financial institutions according to business needs.

The above credit limit is not equal to the company's actual credit amount. The company will handle specific business transactions based on actual needs. Within the scope of the above credit limit, the specific credit granting banks and financial institutions and the corresponding credit limit, credit type,

The credit period, guarantee method, etc. are ultimately determined by the actual formal agreement signed between the company and the credit-granting bank or financial institution or

The contract shall prevail.

This application for a comprehensive credit line still needs to be submitted to the company's shareholders' meeting for review. The board of directors proposes to the shareholders’ meeting to approve

The legal representative of the company or its designated authorized person shall be authorized to handle matters related to the above credit line and sign relevant documents.

(2) Provide guarantee lines for subsidiaries

1. Overview of guarantee situation In order to better meet the daily operations and business development needs of the company and its subsidiaries, the company plans to

The subsidiaries within the scope of the following consolidated statements provide financing guarantees in the form of joint liability guarantees.

The expected guarantee amount will not exceed RMB 11,678.25 million or its equivalent in foreign currency. All are expected to be liabilities to assets

The guarantee limit provided to subsidiaries with an asset-liability ratio of less than 70% does not involve providing guarantees to subsidiaries with an asset-liability ratio of more than 70%. The company provides a guarantee line. The above guarantee amount includes new guarantees and extensions or renewals of original guarantees. The actual guarantee

The amount and guarantee period shall be subject to the final signed guarantee contract.

The guarantee limit is expected to be valid from the date of review and approval by the shareholders' meeting to the next review as a subsidiary Until the date of the shareholders' meeting to provide guarantee proposals, all guarantees signed during the period are valid.

The validity period follows the terms of the signed guarantee contract, and the guarantee period shall not exceed 3 years. Guaranteed amount within the validity period

The guarantee balance can be recycled, and the guarantee balance at any point in time shall not exceed the approved guarantee limit.

2. Overall guarantee amount

The overall guarantee amount is expected to be as follows: Unit: 10,000 yuan

New guarantee limit secured party Account for the largest share of listed companies? Order Guarantee Guarantee Holder Latest Issue Up to Now This New Guarantee Secured party’s most recent audited relationship No. Party Share Ratio Assets and Liabilities Guarantee Balance Guaranteed Amount Guarantee of net assets attributable to parent company rate Proportion Livzon Group Livzon 1 Company 100% 20.64% 20,076.88 279,700.00 20.14% No pharmaceutical factory Zhuhai Free Trade Zone 2 Company Zhu Hesheng Pharmaceutical has 100% 29.44% 9,696.13 211,200.00 15.21% No Ltd. Zhuhai Lizhu Hospital 3 Company Pharmaceutical Trading Co., Ltd. 100% 52.48% 0 170,250.00 12.26% No Division Livzon Group New Taipei 4 Company Jiang Pharmaceutical Co., Ltd. 87.14% 18.95% 433.89 110,475.00 7.95% No Ltd. Livzon Group Fuzhou 5 Company Fuxing Pharmaceutical Co., Ltd. 90.36% 17.70% 7,950.60 87,250.00 6.28% No company Livzon Group (Ning 6 Company Xia) Pharmaceutical Co., Ltd. 87.14% 27.59% 15,262.26 68,000.00 4.90% No company

Sichuan Everbright Pharmaceutical 7 Company 100% 24.69% 3,619.40 49,500.00 3.56% No Ltd.

New guarantee limit secured party Account for the largest share of listed companies? Order Guarantee Guarantee Holder Latest Issue Up to Now This New Guarantee Secured party’s most recent audited relationship No. Party Share Ratio Assets and Liabilities Guarantee Balance Guaranteed Amount Guarantee of net assets attributable to parent company rate Proportion Livzon Group benefits the people 8 Company 100% 8.92% 340.01 7,500.00 0.54% No pharmaceutical factory Jiaozuo Livzon synthesis 9 Company 100% 68.47% 18,411.33 65,000.00 4.68% No Pharmaceutical Co., Ltd. Zhuhai Livzon Micro 10 Company Ball Technology Co., Ltd. 100% 16.42% 0 55,200.00 3.97% No Division Gutian Fuxing Pharmaceutical 11 Company 92.77% 14.35% 676.47 25,750.00 1.85% No Ltd. Zhuhai Lizhu Middle 12 Company Pharmaceutical Modernization Technology 100% 3.06% 0 38,000.00 2.74% No Ltd. Total 76,466.97 1,167,825.00 84.09% Note:

1. "Guarantee balance to date" is the guarantee balance as of February 28, 2025.
2. The asset-liability ratio of the guaranteed object is calculated based on the financial data on December 31, 2025.
3. Zhuhai Zhonghuiyuan Investment Partnership, another shareholder of Livzon Group Xinbeijiang Pharmaceutical Co., Ltd. (hereinafter referred to as "Xinbeijiang Company") Industry (Limited Partnership) (holding 8.44% of the equity of Xinbeijiang Company) issued a "Letter of Counter Guarantee Commitment", promising to provide Livzon Group with Jiang Company assumes joint and several liability for 8.44% of the company's guarantee liability, and the guarantee period ends on the date when Livzon Group's guarantee liability ends. The estimated guarantee amount of each guaranteed party is as follows:

Unit: 10,000 yuan Secured Party Credit Institution Currency New Guarantee Amount Guarantee Period Remarks China Development Bank RMB 10,000.00 3 Export-Import Bank of China RMB 10,000.00 3

Bank of China Co., Ltd. RMB 20,000.00 3 Agricultural Bank of China Co., Ltd. RMB 8,000.00 3 Industrial and Commercial Bank of China Co., Ltd. RMB 30,200.00 3 China Construction Bank Co., Ltd. RMB 20,000.00 3

Livzon Group Bank of Communications Co., Ltd. RMB 25,000.00 3 Zhu Pharmaceutical Factory Postal Savings Bank of China Co., Ltd. RMB 10,000.00 3 China Merchants Bank Co., Ltd. RMB 30,000.00 3 Shared with the group China Minsheng Bank Co., Ltd. RMB 20,000.00 3

China Everbright Bank Co., Ltd. RMB 10,000.00 3 Shared with the group China CITIC Bank Co., Ltd. RMB 30,000.00 3 Industrial Bank Co., Ltd. RMB 30,000.00 3 Zhuhai China Resources Bank Co., Ltd. RMB 15,000.00 3

Secured Party Credit Institution Currency New Guarantee Amount Guarantee Period Remarks Standard Chartered Bank (China) Co., Ltd. RMB 11,500.00 3 Shared with the group Total 279,700.00

China Development Bank RMB 10,000.00 3 Bank of China Co., Ltd. RMB 10,000.00 3 Industrial and Commercial Bank of China Co., Ltd. RMB 15,200.00 3 China Construction Bank Co., Ltd. RMB 10,000.00 3 Bank of Communications Co., Ltd. RMB 20,000.00 3

China Guangfa Bank Co., Ltd. RMB 25,000.00 3 Postal Savings Bank of China Co., Ltd. RMB 5,000.00 3 Zhuhai Free Trade Zone China Merchants Bank Co., Ltd. RMB 28,000.00 3 Shared with the group Livzon synthetic China Minsheng Bank Co., Ltd. RMB 20,000.00 3 Pharmaceutical Co., Ltd. China Everbright Bank Co., Ltd. RMB 10,000.00 3 Shared with the group China CITIC Bank Co., Ltd. RMB 10,000.00 3 Industrial Bank Co., Ltd. RMB 10,000.00 3 Shanghai Pudong Development Bank Co., Ltd. RMB 5,000.00 3 Zhuhai China Resources Bank Co., Ltd. RMB 10,000.00 3 Standard Chartered Bank (China) Co., Ltd. RMB 23,000.00 3 Shared with the group Total 211,200.00 China Development Bank RMB 10,000.00 3 Export-Import Bank of China RMB 10,000.00 3 Bank of China Co., Ltd. RMB 10,000.00 3 Agricultural Bank of China Co., Ltd. RMB 7,000.00 3 Industrial and Commercial Bank of China Co., Ltd. RMB 7,000.00 3

China Construction Bank Co., Ltd. RMB 10,000.00 3 Bank of Communications Co., Ltd. RMB 15,000.00 3 China Merchants Bank Co., Ltd. RMB 15,500.00 3 Shared with the group Zhuhai Livzon China Minsheng Bank Co., Ltd. RMB 20,000.00 3 Pharmaceutical trade has China Everbright Bank Co., Ltd. RMB 10,000.00 3 Shared with the group Ltd. China CITIC Bank Co., Ltd. RMB 10,000.00 3 Industrial Bank Co., Ltd. RMB 5,000.00 3 Zheshang Bank Co., Ltd. RMB 10,000.00 3 Shared with the group Zhuhai China Resources Bank Co., Ltd. RMB 10,000.00 3 Standard Chartered Bank (China) Co., Ltd. RMB 5,750.00 3 Shared with the group HSBC Bank (China) Co., Ltd. RMB 10,000.00 3 Shared with the group Huaxia Bank Co., Ltd. RMB 5,000.00 3 Total 170,250.00 China Development Bank RMB 10,000.00 3 Export-Import Bank of China RMB 10,000.00 3 Livzon Group New Agricultural Bank of China Co., Ltd. RMB 10,000.00 3 Beijiang Pharmaceutical Stocks Industrial and Commercial Bank of China Co., Ltd. RMB 10,000.00 3 Co., Ltd. Bank of Communications Co., Ltd. RMB 10,000.00 3 China Merchants Bank Co., Ltd. RMB 28,000.00 3 Shared with the group

Secured Party Credit Institution Currency New Guarantee Amount Guarantee Period Remarks China CITIC Bank Co., Ltd. RMB 10,000.00 3 Industrial Bank Co., Ltd. RMB 5,000.00 3

Standard Chartered Bank (China) Co., Ltd. RMB 7,475.00 3 Shared with the group HSBC Bank (China) Co., Ltd. RMB 10,000.00 3 Shared with the group Total RMB 110,475.00 China Construction Bank Co., Ltd. RMB 20,000.00 3 Bank of Communications Co., Ltd. RMB 10,000.00 3

Livzon Group Fortune China Merchants Bank Co., Ltd. RMB 20,000.00 3 Shared with the group Zhou Fuxing Pharmaceutical Industrial Bank Co., Ltd. RMB 10,000.00 3 Ltd. China CITIC Bank Co., Ltd. RMB 10,000.00 3 Standard Chartered Bank (China) Co., Ltd. RMB 17,250.00 3 Shared with the group

Total RMB 87,250.00 Bank of Communications Co., Ltd. RMB 15,000.00 3 China Merchants Bank Co., Ltd. RMB 10,000.00 3 Shared with the group Livzon Group Industrial Bank Co., Ltd. RMB 10,000.00 3 Made in (Ningxia) China CITIC Bank Co., Ltd. RMB 10,000.00 3 Pharmaceutical Co., Ltd. Standard Chartered Bank (China) Co., Ltd. RMB 23,000.00 3 Shared with the group Total 68,000.00 Bank of Communications Co., Ltd. RMB 10,000.00 3 Industrial Bank Co., Ltd. RMB 10,000.00 3 Sichuan Everbright China Merchants Bank Co., Ltd. RMB 8,000.00 3 Shared with the group Pharmaceutical Co., Ltd. China CITIC Bank Co., Ltd. RMB 10,000.00 3 Standard Chartered Bank (China) Co., Ltd. RMB 11,500.00 3 Shared with the group Total 49,500.00 Bank of Communications Co., Ltd. RMB 1,500.00 3 Livzon Group's profit Industrial Bank Co., Ltd. RMB 5,000.00 3 Min Pharmaceutical Factory China Merchants Bank Co., Ltd. RMB 1,000.00 3 Shared with the group Total 7,500.00

Bank of Communications Co., Ltd. RMB 15,000.00 3 Industrial Bank Co., Ltd. RMB 10,000.00 3 Jiaozuo Lizhuhe China Merchants Bank Co., Ltd. RMB 7,000.00 3 Shared with the group Cheng Pharmaceutical Co., Ltd. China CITIC Bank Co., Ltd. RMB 10,000.00 3 company Standard Chartered Bank (China) Co., Ltd. RMB 23,000.00 3 Shared with the group Total 65,000.00 Bank of China Co., Ltd. RMB 10,000.00 3 Agricultural Bank of China Co., Ltd. RMB 10,000.00 3 Zhuhai Livzon Industrial and Commercial Bank of China Co., Ltd. RMB 10,200.00 3 Microsphere Technology has Bank of Communications Co., Ltd. RMB 10,000.00 3 Co., Ltd. China Merchants Bank Co., Ltd. RMB 10,000.00 3 Shared with the group Industrial Bank Co., Ltd. RMB 5,000.00 3 Total 55,200.00 Gutian Fuxing Medical China Construction Bank Co., Ltd. RMB 5,000.00 3

Secured Party Credit Institution Currency New Guarantee Amount Guarantee Period Remarks Pharmaceutical Co., Ltd. Bank of Communications Co., Ltd. RMB 5,000.00 3 China Merchants Bank Co., Ltd. RMB 5,000.00 3 Shared with the group

Industrial Bank Co., Ltd. RMB 5,000.00 3 Standard Chartered Bank (China) Co., Ltd. RMB 5,750.00 3 Shared with the group Total 25,750.00 Bank of China Co., Ltd. RMB 5,000.00 3 China Construction Bank Co., Ltd. RMB 5,000.00 3

Zhuhai Livzon China Merchants Bank Co., Ltd. RMB 8,000.00 3 Shared with the group Modernization of Traditional Chinese Medicine China Minsheng Bank Co., Ltd. RMB 5,000.00 3 Technology Co., Ltd. China CITIC Bank Co., Ltd. RMB 5,000.00 3 Company China Everbright Bank Co., Ltd. RMB 5,000.00 3 Shared with the group

Zhuhai China Resources Bank Co., Ltd. RMB 5,000.00 3 Total RMB 38,000.00 Total 1,167,825.00 —— ——

3. Others

The above guarantee amount for each subsidiary is an estimate based on its business development and may occur due to Make corresponding adjustments according to the actual situation of production and operation. Within the scope permitted by relevant regulations, all subsidiaries (including new ones in the future)

The guarantee amount of subsidiaries included in the scope of consolidated statements) can be adjusted to the total guarantee amount in 2026 based on the actual situation.

Subsidiaries whose asset-liability ratio is above 70% when the transfer occurs can only be transferred within the expected quota range.

Can obtain guarantee lines from subsidiaries with an asset-liability ratio of more than 70% at the time of shareholder meeting review. In the above amount

If the guarantee limit adjustment occurs within the period, no separate board of directors or shareholders meeting will be held.

2. Basic information of the guaranteed person

(1) Basic information of the guaranteed party

Preface Date of establishment Legal representative Registered capital and company Company name Registration place Main business Equity structure No. Period Reporter (10,000 yuan) Relationship Livzon Pharmaceutical Group Co., Ltd. Livzon Group L1989- Chuangye North, Jinwan District, Zhuhai City Wholly owned subsidiary 74.46%; Antao Development Co., Ltd. 1 Xu Xiao 45,000 Pharmaceutical Manufacturing No. 38, No. 11-26 Road, Zhu Pharmaceutical Factory Company 24.57%; Livzon (Macau) Co., Ltd. Division 0.97% Zhuhai Free Trade Zone 1993- 22 Lianfeng Road, Zhuhai Free Trade Zone Wholly owned subsidiary Lian Hong Kong Co., Ltd. 90.00%; 2 Livzon Synthetic Manufacturing Zheng Tao 12,828 Pharmaceutical Manufacturing No. 09-09 Company Livzon Group Livzon Pharmaceutical Factory 10% Pharmaceutical Co., Ltd. Entrepreneurship North, Jinwan District, Zhuhai City Zhuhai Livzon Livzon Pharmaceutical Group Co., Ltd. 1991- Wholly owned subsidiary of Livzon Industrial Park, No. 38 Road 3 Pharmaceutical trade includes Zheng Tao 6,000 Commodity trade 66.67%; Livzon Group Livzon Pharmaceutical Factory 06-22 Administration Building 5th Floor 513, Company Co., Ltd. 33.33% Room 515, 516, 517

Preface Date of establishment Legal representative Registered capital and company Company name Registration place Main business Equity structure No. Period Reporter (10,000 yuan) Relationship Livzon Pharmaceutical Group Co., Ltd. Livzon Group holds 87.14% of the new shares, Zhuhai Zhonghuiyuan Investment 1993- Qingyuan City, Guangdong Province People’s First Holdings Subsidiary 4 Beijiang Pharmaceutical Stock Yang Tongsheng 23,988.77 Pharmaceutical Manufacturing Investment Partnership (Limited Partnership) 03-28 Road Company Co., Ltd. 8.44%, other legal person shares 2.26%, Internal employee shares are 2.16%. Livzon Group Fujian Jiangyin Industrial Co., Ltd., Fuqing City, Fujian Province Livzon Group Xinbeijiang Pharmaceutical Co., Ltd. 1989- 49.8 million controlled subsidiary 5 Nangang Avenue, Fuxing Pharmaceutical Industry Concentration Zone, Prefecture 8 Wen Junxian Pharmaceutical Manufacturing Co., Ltd. 75%; Antao Development Co., Ltd. $11-$13 company Co., Ltd. No. 25% Livzon Group (Ningxia Pingluo Industrial Park 2011- Controlled subsidiary Livzon Group Xinbeijiang Pharmaceutical Co., Ltd. 6 Xia) Pharmaceutical Co., Ltd. 301 Shigong Qin Gang, south side of the provincial road 20,000 Pharmaceutical manufacturing 08-17 Company Limited holds 100% shares Company road west side Livzon Pharmaceutical Group Co., Ltd. Sichuan Everbright System 1993- Wholly owned subsidiary of Pengzhou City, Chengdu City, Sichuan Province 7 Cai Xinfu 14,900 Pharmaceutical manufacturing 57.41%; British Weiming Investment Co., Ltd. Pharmaceutical Co., Ltd. 12-01 No. 233, Section 2, East Third Ring Road Company Division 42.59% Livzon Pharmaceutical Group Co., Ltd. Livzon Group Li 1997- Wholly owned subsidiary of Gongye West Road, Shaoguan City, Guangdong 8 Huang Wenhua 6,156.101 Pharmaceutical manufacturing 65.10%; Antao Development Co., Ltd. Min Pharmaceutical Factory 05-24 No. 89 Company 34.90% Jiaozuo Livzon Synthetic Pharmaceutical Co., Ltd. Zhuhai Free Trade Zone Livzon Synthetic Pharmaceutical Co., Ltd. 2009- Wholly owned subsidiary of Wanfang Engineering, Macun District, Jiaozuo City 9 Cheng Pharmaceutical Co., Ltd. Zheng Tao 15,520 Pharmaceutical Manufacturing Co., Ltd. 75.00%; Antao Development Co., Ltd. 07-10 Yeyuan Company Company Limited 25% Zhuhai Livzon Livzon Pharmaceutical Group Co., Ltd. 2017- Chuangye North, Jinwan District, Zhuhai City 50,348.68 Wholly-owned subsidiary 10 Microsphere Technology has Wang Yanqing 60% of technology development; Livzon Group Livzon Pharmaceutical Factory Company 5, 3rd Floor, Microsphere Building, No. 38 Road 07-03 Ltd. 40% Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. Gutian Fuxing Medical 1991- controlling subsidiary 11 Songfeng Village, Huangtian Town, Gutian County Wen Junxian 2,670 Pharmaceutical Manufacturing Company 75%; Livzon Pharmaceutical Group Co., Ltd. Pharmaceutical Co., Ltd. 08-21 Company Ltd. 25% Livzon, Zhuhai City, Doukou Road, Hengqin New District, Zhuhai Livzon Pharmaceutical Group Co., Ltd. Modernization of Traditional Chinese Medicine 2021-No. 1 Guangdong-Macao Cooperation in Traditional Chinese Medicine 50% wholly-owned subsidiary; Livzon Group Limin Pharmaceutical Factory 12 Tang Yanggang 13,000 Pharmaceutical manufacturing Science and Technology Co., Ltd. 08-24 Science and Technology Industrial Park Scientific Research Headquarters Company 25%; Sichuan Everbright Pharmaceutical Co., Ltd. Room 412, Division Building 25% (2) Main financial data (audited) Unit: 10,000 yuan January 1, 2025 - December 31, 2025 December 31, 2025 prologue day secured party No. bank loan Total assets Total liabilities Total current liabilities Net assets Operating income Total profits Net profits total payment Livzon Group 1 606,490.29 125,204.09 - 112,474.16 481,286.19 327,875.16 99,798.32 86,609.12 bead pharmaceutical factory

January 1, 2025 - December 31, 2025 December 31, 2025 prologue day secured party No. bank loan Total assets Total liabilities Total current liabilities Net assets Operating income Total profits Net profit total payment Zhuhai Free Trade Zone 2 Livzon synthetic 163,245.80 48,066.87 - 48,039.86 111,873.79 90,401.72 16,830.11 14,142.26 Pharmaceutical Co., Ltd. Zhuhai Livzon 3 Pharmaceutical trade has 23,533.98 12,351.47 - 12,005.13 11,182.51 29,908.14 18.24 11.14 Ltd. Livzon Group New 4 Beijiang Pharmaceutical Stock 430,576.17 81,595.64 - 76,548.47 304,466.25 249,914.79 77,080.14 54,442.44 Co., Ltd. Livzon Group 5 Zhou Fuxing Pharmaceutical 203,873.89 36,076.38 - 31,864.47 164,376.99 119,616.94 55,896.30 48,065.69 Ltd.

Livzon Group (Ning 6 Xia) Pharmaceutical Co., Ltd. 125,129.31 34,524.25 - 34,509.94 90,605.06 106,029.23 22,437.73 19,099.72 company Sichuan Everbright System 7 185,479.66 45,803.84 - 37,934.01 139,675.82 51,150.56 9,424.11 8,138.25 Pharmaceutical Co., Ltd. Livzon Group's profit 8 108,840.80 9,707.94 - 7,978.41 99,997.04 73,239.45 37,115.21 32,450.38 civilian pharmaceutical factory Jiaozuo Lizhuhe 9 Cheng Pharmaceutical Co., Ltd. 41,932.12 28,711.57 - 28,701.32 13,220.55 38,703.56 2,054.33 1,736.38 company Zhuhai Livzon 10 Microsphere Technology has 31,949.61 5,246.63 - 2,977.43 26,702.98 3,298.90 -7,780.31 -7,780.31 Ltd.

Gutian Fuxing Medical 11 15,974.50 2,292.42 - 1,936.50 13,682.08 6,389.86 1,347.37 1,005.36 Pharmaceutical Co., Ltd. Zhuhai Livzon Modernization of traditional Chinese medicine 12 4,268.91 130.56 - 130.56 3,905.82 2,170.10 -2,730.31 -2,719.68 Technology Co., Ltd. Division

(3) Credit status of the guaranteed party

The above-mentioned guaranteed parties are all subsidiaries included in the company's consolidated statements and have good credit status. After investigation

Upon inquiry, none of the above-mentioned secured parties are the persons subject to execution for breach of trust.

3. Main contents of the guarantee agreement

The above guarantee is an estimated amount of the proposed guarantee. The relevant guarantee agreement has not yet been signed. The main content of the guarantee agreement is

The content will be determined by the company and its subsidiaries through consultation with financial institutions or other relevant parties. The specific guarantee amount, guarantee

Terms such as the method will be subject to the officially signed guarantee document within the scope of authorization.

4. Opinions of the Board of Directors

The company's application for comprehensive credit and the provision of guarantees for subsidiaries are intended to meet the daily operating needs of the company and its subsidiaries.

To meet operating business needs, it will help improve financing efficiency and reduce financing costs. The company provides guarantees for the above-mentioned subsidiaries. In line with the overall interests of the company.

The guaranteed objects this time are all subsidiaries within the scope of the company's consolidated statements, and the company has control over them.

Able to implement effective management in business, finance, capital, personnel and other aspects. At present, the production experience of the guaranteed objects is

The business is operating normally, the credit status is good, the company has the ability to repay debts, and there is no record of overdue repayment. The above-mentioned holdings receiving guarantees

Among the subsidiaries, other shareholders of Xinbeijiang Company, Zhuhai Zhonghuiyuan Investment Partnership (Limited Partnership) (holding Xinbeijiang Company (8.44% equity) issued a "Counter Guarantee Commitment Letter", promising to provide Livzon Group with

Within the scope of guarantee liability, a joint guarantee liability of 8.44% is provided; in addition, Livzon Group (Ningxia) Pharmaceutical Co., Ltd.

The company is a wholly-owned subsidiary of Xinbeijiang Company, Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd., Gutian Fuxing Medical

Pharmaceutical Co., Ltd. is jointly held by Xinbeijiang Company and the company or its wholly-owned subsidiaries. There are no other shareholders holding shares.

The board of directors, after careful evaluation, believes that the risks of this arrangement are controllable and will not harm the company. and shareholder interests.

In summary, the board of directors believes that the risks of applying for comprehensive credit and providing guarantees this time are controllable and will not have any impact on the company.

has a significant adverse impact on the normal operation and business development of the company and does not harm the interests of the company and all shareholders.

According to the situation, the board of directors agreed to the comprehensive credit and guarantee limit estimates for this application, and agreed to submit them to the company’s shareholders’ meeting.

Deliberation.

5. Cumulative number of external guarantees and number of overdue guarantees

After this guarantee, the total guarantee amount of the company and its holding subsidiaries is RMB 13,778.25 million, accounting for

The company’s audited proportion of net assets attributable to shareholders of the parent company in 2025 (13,888,350,600 yuan) is

99.21%. As of February 28, 2026, the total balance of external guarantees of the company and its holding subsidiaries was 162,314.82

Ten thousand yuan, accounting for 13,888,350,600 yuan of the company’s audited net assets attributable to shareholders of the parent company in 2025 (13,888,350,600 yuan)

The ratio is 11.69%, all of which are guarantees provided by the company to its subsidiaries. The company does not provide information to units outside the consolidated statements

There are no guarantees for overdue debts, no guarantees involved in litigation, and no lawsuits have been lost due to guarantees.

The amount of losses that should be borne, etc.

6. Documents available for inspection

Resolution of the 33rd meeting of the 11th board of directors of the company.

Announcement is hereby made.

Board of Directors of Livzon Pharmaceutical Group Co., Ltd.

March 25, 2026